Home/Filings/4/0000899243-19-001254
4//SEC Filing

Reisman Neil 4

Accession 0000899243-19-001254

CIK 0001576263other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 9:15 PM ET

Size

17.9 KB

Accession

0000899243-19-001254

Insider Transaction Report

Form 4
Period: 2019-01-11
Reisman Neil
10% Owner
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-1110,0000 total
    Exercise: $27.00Exp: 2019-03-06Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-11$27.00/sh+10,000$270,00023,131 total
  • Tax Payment

    Common Stock

    2019-01-11$60.20/sh50$3,01033,397 total
  • Exercise/Conversion

    Common Stock

    2019-01-11$4.05/sh+15,972$64,68739,103 total
  • Tax Payment

    Common Stock

    2019-01-11$59.50/sh5,656$336,53233,447 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-1115,9720 total
    Exercise: $4.05Exp: 2019-03-06Common Stock (15,972 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    1,565,560
  • Common Stock

    (indirect: See footnote)
    513,630
Footnotes (6)
  • [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $59.10 to $60.00.
  • [F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd., (ii) Boxer Capital, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC ("MVA Investors"), (v) Tuesday Thirteen Inc., (vi) Joseph C. Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) the reporting person, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang. The reporting person is a member of Boxer Capital. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
  • [F3]These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. The reporting person is a member of MVA Investors. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
  • [F4]On January 18, 2018, the reporting person was granted an option to purchase 10,000 shares of common stock. 1/12th of the shares underlying the option vest each month until the shares subject to the option are fully vested on the one-year anniversary of the date of grant. On December 6, 2018, in connection with the resignation of the reporting person from the board of directors (the "Board"), vesting under the option was fully accelerated.
  • [F5]On June 22, 2017, the reporting person was granted an option to purchase 25,000 shares of common stock. 1/36th of the shares underlying the option vest each month until the shares subject to the option are fully vested on the three-year anniversary of the date of grant. On December 6, 2018, in connection with the resignation of the reporting person from the Board, vesting under the option was accelerated through May 31, 2019.
  • [F6]The reporting person had 90 days from the date of his resignation from the Board to exercise his vested options.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001465834

Filing Metadata

Form type
4
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 9:15 PM ET
Size
17.9 KB